- Research works
- 38 ▲ 332% vs 2013–17
- Citations
- 1.1k 27.8 per fractional work
- Top-10% rate
- 14.9% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: HiFiBiO Therapeutics (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 13.0×. Every wedge is a field page.
Which keywords describe research at HiFiBiO Therapeutics (France)?
By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Innate Immunity, Neuroinflammation, Inflammation, Alzheimer's Disease, Cancer Immunotherapy, Neurodegeneration and Neurodegenerative Diseases.
- cancer development
- 14-3-3 Proteins
- Monoclonal Antibodies
- Homologous Recombination
- Membrane Proteins
- Biomarkers
- Normalization
- Glycosylation
- Data Analysis
- Antigen Presentation
- Gene Therapy
- Gene Expression
- Immunity
- Cancer Therapy
- Toxicology
- Neurodegeneration
- Alzheimer's Disease
- Cancer
- Inflammation
- Oxidative Stress
- Innate Immunity
- Neuroinflammation
- Cancer Immunotherapy
- Neurodegenerative Diseases
- Acetylcholinesterase
- Cholinesterase Inhibitors
- Neurological Disorders
- Amyloid Hypothesis
- Tau Pathology
- Dendritic Cells
- Genomic Instability
- Machine Learning
- Aging
- Cell Signaling
- Epidemiology
- Molecular Chaperones
- Therapeutic Antibodies
- Host Defense
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Oxidative Stress4▲ 5.9×15 topics
- Inflammation3▲ 3.7×17 topics
- Innate Immunity3▲ 23×7 topics
- Cancer2▲ 4.6×12 topics
- Neuroinflammation2▲ 23×4 topics
- Alzheimer's Disease2▲ 20×2 topics
- Cancer Immunotherapy2▲ 39×3 topics
- Neurodegeneration2▲ 17×6 topics
- Neurodegenerative Diseases2▲ 24×2 topics
- Toxicology2▲ 24×3 topics
- Acetylcholinesterase2▲ 165×1 topic
- Cancer Therapy2▲ 7.3×10 topics
- Cholinesterase Inhibitors2▲ 165×1 topic
- Immunity2▲ 14×5 topics
- Neurological Disorders2▲ 7.1×6 topics
- Gene Expression2▲ 6.7×5 topics
- Amyloid Hypothesis2▲ 72×1 topic
- Gene Therapy2▲ 15×3 topics
- Tau Pathology2▲ 72×1 topic
- Antigen Presentation1▲ 37×1 topic
- Dendritic Cells1▲ 33×1 topic
- Data Analysis1▲ 11×2 topics
- Genomic Instability1▲ 27×2 topics
- Glycosylation1▲ 15×2 topics
- Machine Learning1▲ 1.54×4 topics
- Normalization1▲ 48×2 topics
- Aging1▲ 5.8×3 topics
- Biomarkers1▲ 5.2×4 topics
- Cell Signaling1▲ 9.6×3 topics
- Membrane Proteins1▲ 17×2 topics
- Epidemiology1▼ 0.72×10 topics
- Homologous Recombination1▲ 44×2 topics
- Molecular Chaperones1▲ 91×2 topics
- Monoclonal Antibodies1▲ 19×2 topics
- Therapeutic Antibodies1▲ 22×2 topics
- 14-3-3 Proteins1▲ 289×1 topic
- Host Defense1▲ 41×2 topics
- cancer development1▲ 289×1 topic
Which research topics does HiFiBiO Therapeutics (France) publish most on?
By volume in 2022–2025: Trace Elements in Health, Frailty in Older Adults, CAR-T cell therapy research and Virus-based gene therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Trace Elements in Health Nutrition and Dietetics 1 works
- 2 Frailty in Older Adults Geriatrics and Gerontology 0 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Virus-based gene therapy research Genetics 0 works
- 5 DNA Repair Mechanisms Molecular Biology 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 CRISPR and Genetic Engineering Molecular Biology 0 works
- 8 Immunotherapy and Immune Responses Immunology 0 works
- 9 Health, Environment, Cognitive Aging Health, Toxicology and Mutagenesis 0 works
- 10 Mesenchymal stem cell research Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has HiFiBiO Therapeutics (France)'s research output changed?
Output in 2018–2022 was 332% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.